++
Tables AII–1 and AII–2 present a perspective on drug-drug interactions as examined by the effect that one drug (the perpetrator) can have on the area under the plasma concentration versus time curve (AUC) of another drug (the victim). The cutoff value of 5-fold change in the AUC of the victim drug was chosen in order to focus these tables on clinically significant drug-drug interactions that would generally contraindicate the coadministration of the drugs or at least require dosage adjustment.
++++